» Articles » PMID: 3196704

Anion-binding Exosite of Human Alpha-thrombin and Fibrin(ogen) Recognition

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1988 Sep 6
PMID 3196704
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of prothrombin to alpha-thrombin generates not only the catalytic site and associated regions but also an independent site (an exosite) which binds anionic substances, such as Amberlite CG-50 resin [cross-linked poly(methylacrylic acid)]. Like human alpha-thrombin with high fibrinogen clotting activity (peak elution at I = 0.40 +/- 0.01 M, pH 7.4, approximately 23 degrees C), catalytically inactivated forms (e.g., i-Pr2P-alpha- and D-Phe-Pro-Arg-CH2-alpha-thrombins) were eluted with only slightly lower salt concentrations (I = 0.36-0.39 M), while gamma-thrombin with very low clotting activity was eluted with much lower concentrations (I = 0.29 M) and the hirudin complex of alpha-thrombin was not retained by the resin. In a similar manner, hirudin complexes of alpha-, i-Pr2P-alpha-, and gamma-thrombin were not retained by nonpolymerized fibrin-agarose resin. Moreover, the ionic strengths for the elution from the CG-50 resin of seven thrombin forms were directly correlated with those from the fibrin resin (y = 0.15 + 0.96x, r = 0.95). In other experiments, the 17 through 27 synthetic peptide of the human fibrinogen A alpha chain was not an inhibitor of alpha-thrombin, while the NH2-terminal disulfide knot (NDSK) fragment was a simple competitive inhibitor of alpha-thrombin with a Ki approximately 3 microM (0.15 M NaCl, pH 7.3, approximately 23 degrees C). These data suggest that alpha-thrombin recognizes fibrin(ogen) by a negatively charged surface, noncontiguous with the A alpha cleavage site but found within the NDSK fragment. Such interaction involving an anion-binding exosite may explain the exceptional specificity of alpha-thrombin for the A alpha cleavage in fibrinogen and alpha-thrombin incorporation into fibrin clots.

Citing Articles

Thrombin: An Approach to Developing a Higher-Order Reference Material and Reference Measurement Procedure for Substance Identity, Amount, and Biological Activities.

Jackson C, Esnouf P, Duewer D J Res Natl Inst Stand Technol. 2024; 125:125021.

PMID: 39035347 PMC: 10871826. DOI: 10.6028/jres.125.021.


Rapid molecular imaging of active thrombi using aptamer-antidote probes.

Powell Gray B, Kelly L, Steen-Burrell K, Layzer J, Rempel R, Nimjee S Mol Ther Nucleic Acids. 2023; 31:440-451.

PMID: 36817726 PMC: 9930157. DOI: 10.1016/j.omtn.2023.01.009.


Exosite Binding in Thrombin: A Global Structural/Dynamic Overview of Complexes with Aptamers and Other Ligands.

Troisi R, Balasco N, Autiero I, Vitagliano L, Sica F Int J Mol Sci. 2021; 22(19).

PMID: 34639143 PMC: 8509272. DOI: 10.3390/ijms221910803.


Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1.

Gonzalez Ramirez M, Poreba M, Snipas S, Groborz K, Drag M, Salvesen G J Biol Chem. 2018; 293(18):7058-7067.

PMID: 29414788 PMC: 5936834. DOI: 10.1074/jbc.RA117.001329.


Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.

Gonzales J, Kim K, Zemskova M, Rafikov R, Heeke B, Varn M Vascul Pharmacol. 2014; 62(2):63-71.

PMID: 24469066 PMC: 4111793. DOI: 10.1016/j.vph.2014.01.005.